Cancer

Views & Analysis

The new pharma collaborations driving transformative researc...

The pharmaceutical industry is one of the most scientifically innovative and competitive industries, particularly in oncology.

Views & Analysis

Clinical decision-making insights for haematologists and onc...

Clinical trial readouts continue to emerge despite countries’ lockdown policies, providing several decision-making challenges for healthcare professionals such as haematologists and oncolog

Partner Content

Partner Content

J+D Forecasting strike the balance for the liquid tumour mar...

Greater confidence in outputs and decision-making

News

Amgen offers hope in KRAS-mutated cancer with sotorasib read...

Last year Amgen intrigued scientists and investors alike after announcing data showing it had produced the first drug that seemed to work against KRAS mutations, which are found in lung and

News

EU regulators back uses for AZ's Lynparza in prostate and ov...

AstraZeneca may have had a rough ride following a safety scare with its COVID-19 vaccine, but the company’s busy pipeline is producing successes in other areas.

News

Sanofi/Regeneron's Libtayo set for new skin cancer use

Sanofi and Regeneron plan to file their cancer immunotherapy Libtayo (cemiplimab) in a new indication following supportive findings from a phase 2 trial in a hard to treat group of skin can

The new pharma collaborations driving transformative researc...

Clinical decision-making insights for haematologists and onc...

J+D Forecasting strike the balance for the liquid tumour mar...

Amgen offers hope in KRAS-mutated cancer with sotorasib read...

EU regulators back uses for AZ's Lynparza in prostate and ov...

Sanofi/Regeneron's Libtayo set for new skin cancer use

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks